NCT00265005View on ClinicalTrials.gov

Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants

PHASE1TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2012

Conditions

Thrombosis

Interventions

DRUG

alteplase

Iv administration of 1 mg/ml up to two times and 2 mg/ml if needed.

Trial Locations (1)

40202

University of Louisville, Louisville

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of Louisville

OTHER